Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about NVS

Recent news which mentions NVS

< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
26 27 Next >
Bausch + Lomb to buy ‘dry eye’ treatment from Novartis in a $2.5 billion deal
Tickers BLCO NVS SPX XLV
Tags XLV NVS BLCO
From MarketWatch
Amazon Hires Dozens of Former FTC Officials, Volkswagen Discusses With Tesla to Adopt North American Charging Standard, FDA Approves First Hemophilia A BioMarin Gene Therapy: Today's Top Stories
Tickers AMZN BA BLCO BMRN
Tags GM VWAGY TSLA
From Benzinga
Bausch + Lomb Poised To Boost Presence In Growing Market With Potential $1.75B Drug Acquisition Deal From Novartis
Tickers ABBV BHC BLCO NVS
Tags Benzinga Health Care why it's moving
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Tickers ACAD AMGN BAX CVS
Tags ISRG NVS Options
From Benzinga
Amgen Out, Rio Tinto In As Morgan Stanley Shuffles Dividend Deck
Tickers AMGN DEM EWH MS
Tags Sector ETFs MS AMGN
From Benzinga
7 Top Growth Stocks to Watch for H2 2023
Tickers AAPL ABBV ALC CMG
Tags NVDA Stocks to Buy ORCL
From InvestorPlace
Fusion Pharmaceuticals is Future Pillar of Cancer Treatment: Analyst
Tickers AZN BAYRY FUSN NVS
Tags Analyst Ratings Biotech NVS
From Benzinga
Terns Pharma Has 35% Upside According To This Analyst, NASH Asset To Drive Valuation
Tickers LLY NVO NVS TERN
Tags Health Care Benzinga Trading Ideas
From Benzinga
Why Shares of Vera Therapeutics Jumped Tuesday
Tickers KDNY NVS VERA
Tags KDNY Market News Recent Press Releases
From Motley Fool
Why Investors Should Care About Novartis' Latest Label Expansion -- It Could Mean Billions
Tickers ABBV NVS
Tags Market News ABBV Recent Press Releases
From Motley Fool
Coherus BioSciences Acquires Small Immuno-Oncology Player Surface Oncology For $40M
Tickers CHRS GSK NVS SURF
Tags Penny Stocks Health Care Trading Ideas
From Benzinga
Investor Opportunities Ahead of Clinical Updates, Says Analyst Initiating Coverage on Ambrx Biopharma with 'Buy' Rating
Tickers AMAM AZN NVS PFE
Tags NVS AMAM Analyst Ratings
From Benzinga
KDNY Stock Alert: Why Short Seller Muddy Waters Is Betting Against Chinook
Tickers KDNY NVS
Tags NASDAQ:KDNY,NYSE:NVS NVS KDNY
From InvestorPlace
Novartis deal for Chinook makes kidney-treatment competitors more attractive, analysts say
Tickers KDNY NVS TVTX VERA
Tags VERA KDNY NVS
From MarketWatch
Health Care Company Novartis Announces Merger With Chinook Therapeutics
Tickers KDNY NVS
Tags BZI/MA KDNY M&A
From Benzinga
XPeng's New EV Is a Hit, but This Biotech Stock Is Leaving It in the Dust
Tickers ABBV KDNY NVS TSLA
Tags ABBV XPEV Market News
From Motley Fool
Broadcom Might Receive European Approval For $61B VMware Deal, UBS Closes Credit Suisse Takeover, Illumina CEO Steps Down Amid Activist Investor Carl Icahn's Pressure: Today's Top Stories
Tickers AVGO BNTX CS GTLS
Tags Markets NVO GTLS
From Benzinga
Why Is Chinook Therapeutics (KDNY) Stock Up 58% Today?
Tickers KDNY NVS
Tags KDNY Today's Market Market News
From InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Tickers AUUD BTTR CYXT DATS
Tags VHC MCLD GROM
From InvestorPlace
Why Are Chinook Therapeutics Shares Trading Higher Today
Tickers KDNY NVS
Tags M&A NVS Biotech
From Benzinga
Nasdaq, S&amp;P 500 Futures Signal Strong Start To Week On Hopes Of Fed Pause: Why This Analyst Is Pricing In A 20% Gain From Bear Market Low
Tickers BIIB ESALY ILMN KDNY
Tags SPY Market News QQQ
From Benzinga
Goldman pushes back against bearish Morgan Stanley’s Mike Wilson with new 4,500 S&P 500 target
Tickers AAPL AMC AMD AMZN
Tags KDNY YM00 MULN
From MarketWatch
Novartis agrees to buy Chinook Therapeutics for up to $3.5 billion
Tickers KDNY NVS
Tags KDNY CH:NOVN NVS
From MarketWatch
Amazon Considers Launching Ad-Supported Prime Video Tier, Google & Microsoft Face Backlash For Ad Inclusion In AI Trials, Airbus Records One-Third Jump In May Deliveries: Today's Top Stories
Tickers AMZN BLK DIS EADSY
Tags Top Stories TOSYY TOSBF
From Benzinga
Novartis' Sandoz Foresees Rapid Growth Post Spin-Off in Generics Market Amid Upcoming Patent Expirations
Tickers NVS
Tags Health Care General Briefs
From Benzinga
Is Novartis a Good Stock to Buy Right Now?
Tickers NVS
Tags NVS Market News Recent Press Releases
From Motley Fool
Biotech stocks could soon get a M&A boost. Here are 3 likely takeover plays.
Tickers ABBV ALNY AMGN ARGX
Tags AMGN BMY MRK
From MarketWatch
Looking At Novartis's Recent Unusual Options Activity
Tickers NVS
Tags NVS BZI/UOA Options
From Benzinga
Avrobio Stock Jumps On Sale Of Gene Therapy Program To Novartis
Tickers AVRO NVS
Tags Market News Movers Benzinga
From Benzinga
Avrobio Offloads Gene Therapy Program For Rare Genetic Disorder To Novartis
Tickers AVRO NVS
Tags News AVRO General
From Benzinga
< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
26 27 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.